Cozen O’Connor: Schaubert, Keri L.

Keri L. Schaubert, Ph.D.


New York

(212) 883-2258

(212) 986-0604

Keri concentrates her practice on complex patent cases for clients in the pharmaceutical and biotechnology industries. She is a registered patent attorney and represents pharmaceutical companies in Hatch-Waxman and biosimilar litigation.

Prior to attending law school, Keri received her Ph.D. in immunology from Wayne State University School of Medicine where, as a part of her doctoral research, she studied human CD8+ T cell responses to HIV epitopes and mimotopes thereof. Keri then completed a postdoctoral fellowship at the University of Michigan where she examined the role of transforming growth factor-β (TGF-β) in natural killer (NK) cell maturation. Keri has been published in numerous immunology journals.

Keri is also a graduate of Loyola University Chicago School of Law, and earned a bachelor’s degree in biology and anthropology from the University of Michigan.



The Trans-Pacific Partnership and Its Effect On Biosimilars [Inside Counsel]

November 23, 2015

Aaron Lukas and Keri Schaubert, associates of Cozen O’Connor’s IP group, discuss the effect that the Trans-Pacific Partnership will have on the biopharmaceutical and biosimilar industry.


  • Loyola University Chicago School of Law, J.D., 2013
  • Wayne State University of Medicine, Ph.D., 2006
  • University of Michigan, B.S., 2000
  • Illinois
  • United States Patent and Trademark Office